updates on the phase i study of ft-4202 for scd
Published 3 years ago • 62 plays • Length 3:05Download video MP4
Download video MP3
Similar videos
-
2:07
phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
2:11
update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml
-
1:33
an update on the phase i/ii ruby trial of reni-cel gene therapy in patients with severe scd
-
9:25
mgus diagnosis: a step-by-step approach
-
3:56
the future of cancer treatment is here: introducing proton therapy
-
55:29
demystifying end-to-end dna sequencing solutions
-
2:00
the role of fedratinib in 2024 and beyond
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl
-
1:25
the current approach to managing patients with prefibrotic pmf
-
1:23
insights into the management and treatment of accelerated/blast-phase mpns
-
4:38
phase i study of neihulizumab in patients with sr-agvhd or tr-agvhd
-
2:14
long-term follow-up results from the rathl trial: response-adapted treatment for advanced stage hl
-
5:00
long-term results of the phase ii revive study evaluating rusfertide in patients with pv
-
1:17
phase ii study of tosedostat in mds
-
1:19
telomerase inhibition as a novel targeted therapy for myelofibrosis
-
2:25
a final update of enhance: reflecting on the negative read-out of the study
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
2:03
preliminary results of a phase ii study of fedratinib in patients with mds/mpn and cnl
-
1:53
the future of multiple myeloma treatment
-
0:54
a research update in richter's transformation from ash 2023